Acrivon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRV and other ETFs, options, and stocks.About ACRV
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3).
CEOPeter Blume-Jensen
CEOPeter Blume-Jensen
Employees78
Employees78
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2018
Founded2018
Employees78
Employees78
ACRV Key Statistics
Market cap65.63M
Market cap65.63M
Price-Earnings ratio-0.93
Price-Earnings ratio-0.93
Dividend yield—
Dividend yield—
Average volume6.41M
Average volume6.41M
High today$2.16
High today$2.16
Low today$1.99
Low today$1.99
Open price$2.05
Open price$2.05
Volume931.50K
Volume931.50K
52 Week high$8.00
52 Week high$8.00
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
Acrivon Therapeutics(ACRV) stock is priced at $2.08, giving the company a market capitalization of 65.63M. It carries a P/E multiple of -0.93.
On 2026-01-20, Acrivon Therapeutics(ACRV) stock moved within a range of $1.99 to $2.16. With shares now at $2.08, the stock is trading +4.5% above its intraday low and -3.7% below the session's peak.
Trading activity shows a volume of 931.5K, compared to an average daily volume of 6.41M.
The stock's 52-week range extends from a low of $1.05 to a high of $8.00.
The stock's 52-week range extends from a low of $1.05 to a high of $8.00.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own ACRV. This list is generated using Robinhood data, and it’s not a recommendation.